The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Piracetam Injection Market Research Report 2024

Global Piracetam Injection Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1744076

No of Pages : 90

Ask Your Query

Synopsis
It is suitable for memory loss and mild to moderate brain dysfunction caused by various reasons such as acute and chronic cerebrovascular diseases, brain trauma, and various toxic encephalopathy. It is also used for children with mental retardation.

Global Piracetam Injection market is projected to reach US$ 24110 million in 2029, increasing from US$ 2608 million in 2022, with the CAGR of 37.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Piracetam Injection market research.

Brain diseases have always been one of the most difficult areas for human beings to conquer. There are constant disputes over whether neuroprotective agents are life-saving drugs or panacea. The neuroprotective drug market is greatly influenced by evidence-based drug use and related policies. New drugs such as butylphthalide and edaravone dexaborneol are developing rapidly, and after the decline of many old drugs such as edaravone, oxiracetam, and gangliosides, they have taken over and become Dinghaishenzhen among neuroprotective drugs. In addition, piracetam, which is a gamma-aminobutyric acid analogue like oxiracetam, has also been recommended by multiple guidelines, bucking the trend and achieving market growth.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Piracetam Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Tianjin Jinyao Group Hubei Tianyao Pharmaceutical Co., Ltd.
  • Shandong Weigao Pharmaceutical
  • Chongqing Yaoyou Pharmaceutical
  • Harbin Pharmaceutical Group Sanjing Pharmaceutical
  • Yangzhou Pharmaceutical
  • Rapid Life Drugs & Healthcare
  • Mits Healthcare Private Limited
  • Psychocare
  • Shinepro Lifesciences Pvt. Ltd.
  • REPLEK FARM DOOEL
  • Dr Reddy's Laboratories Ltd
  • Heilongjiang Fuhe Pharmaceutical

Segment by Type

  • 15ml
  • 60mL
  • Other

Segment by Application

  • Hospital
  • Clinic

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Piracetam Injection report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Piracetam Injection Market Overview
1.1 Product Overview and Scope of Piracetam Injection
1.2 Piracetam Injection Segment by Type
1.2.1 Global Piracetam Injection Market Value Comparison by Type (2023-2029)
1.2.2 15ml
1.2.3 60mL
1.2.4 Other
1.3 Piracetam Injection Segment by Application
1.3.1 Global Piracetam Injection Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Piracetam Injection Market Size Estimates and Forecasts
1.4.1 Global Piracetam Injection Revenue 2018-2029
1.4.2 Global Piracetam Injection Sales 2018-2029
1.4.3 Global Piracetam Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Piracetam Injection Market Competition by Manufacturers
2.1 Global Piracetam Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Piracetam Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Piracetam Injection Average Price by Manufacturers (2018-2023)
2.4 Global Piracetam Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Piracetam Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Piracetam Injection, Product Type & Application
2.7 Piracetam Injection Market Competitive Situation and Trends
2.7.1 Piracetam Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Piracetam Injection Players Market Share by Revenue
2.7.3 Global Piracetam Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Piracetam Injection Retrospective Market Scenario by Region
3.1 Global Piracetam Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Piracetam Injection Global Piracetam Injection Sales by Region: 2018-2029
3.2.1 Global Piracetam Injection Sales by Region: 2018-2023
3.2.2 Global Piracetam Injection Sales by Region: 2024-2029
3.3 Global Piracetam Injection Global Piracetam Injection Revenue by Region: 2018-2029
3.3.1 Global Piracetam Injection Revenue by Region: 2018-2023
3.3.2 Global Piracetam Injection Revenue by Region: 2024-2029
3.4 North America Piracetam Injection Market Facts & Figures by Country
3.4.1 North America Piracetam Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Piracetam Injection Sales by Country (2018-2029)
3.4.3 North America Piracetam Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Piracetam Injection Market Facts & Figures by Country
3.5.1 Europe Piracetam Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Piracetam Injection Sales by Country (2018-2029)
3.5.3 Europe Piracetam Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Piracetam Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Piracetam Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Piracetam Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Piracetam Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Piracetam Injection Market Facts & Figures by Country
3.7.1 Latin America Piracetam Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Piracetam Injection Sales by Country (2018-2029)
3.7.3 Latin America Piracetam Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Piracetam Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Piracetam Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Piracetam Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Piracetam Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Piracetam Injection Sales by Type (2018-2029)
4.1.1 Global Piracetam Injection Sales by Type (2018-2023)
4.1.2 Global Piracetam Injection Sales by Type (2024-2029)
4.1.3 Global Piracetam Injection Sales Market Share by Type (2018-2029)
4.2 Global Piracetam Injection Revenue by Type (2018-2029)
4.2.1 Global Piracetam Injection Revenue by Type (2018-2023)
4.2.2 Global Piracetam Injection Revenue by Type (2024-2029)
4.2.3 Global Piracetam Injection Revenue Market Share by Type (2018-2029)
4.3 Global Piracetam Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Piracetam Injection Sales by Application (2018-2029)
5.1.1 Global Piracetam Injection Sales by Application (2018-2023)
5.1.2 Global Piracetam Injection Sales by Application (2024-2029)
5.1.3 Global Piracetam Injection Sales Market Share by Application (2018-2029)
5.2 Global Piracetam Injection Revenue by Application (2018-2029)
5.2.1 Global Piracetam Injection Revenue by Application (2018-2023)
5.2.2 Global Piracetam Injection Revenue by Application (2024-2029)
5.2.3 Global Piracetam Injection Revenue Market Share by Application (2018-2029)
5.3 Global Piracetam Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Tianjin Jinyao Group Hubei Tianyao Pharmaceutical Co., Ltd.
6.1.1 Tianjin Jinyao Group Hubei Tianyao Pharmaceutical Co., Ltd. Corporation Information
6.1.2 Tianjin Jinyao Group Hubei Tianyao Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Tianjin Jinyao Group Hubei Tianyao Pharmaceutical Co., Ltd. Piracetam Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Tianjin Jinyao Group Hubei Tianyao Pharmaceutical Co., Ltd. Piracetam Injection Product Portfolio
6.1.5 Tianjin Jinyao Group Hubei Tianyao Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Shandong Weigao Pharmaceutical
6.2.1 Shandong Weigao Pharmaceutical Corporation Information
6.2.2 Shandong Weigao Pharmaceutical Description and Business Overview
6.2.3 Shandong Weigao Pharmaceutical Piracetam Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Shandong Weigao Pharmaceutical Piracetam Injection Product Portfolio
6.2.5 Shandong Weigao Pharmaceutical Recent Developments/Updates
6.3 Chongqing Yaoyou Pharmaceutical
6.3.1 Chongqing Yaoyou Pharmaceutical Corporation Information
6.3.2 Chongqing Yaoyou Pharmaceutical Description and Business Overview
6.3.3 Chongqing Yaoyou Pharmaceutical Piracetam Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Chongqing Yaoyou Pharmaceutical Piracetam Injection Product Portfolio
6.3.5 Chongqing Yaoyou Pharmaceutical Recent Developments/Updates
6.4 Harbin Pharmaceutical Group Sanjing Pharmaceutical
6.4.1 Harbin Pharmaceutical Group Sanjing Pharmaceutical Corporation Information
6.4.2 Harbin Pharmaceutical Group Sanjing Pharmaceutical Description and Business Overview
6.4.3 Harbin Pharmaceutical Group Sanjing Pharmaceutical Piracetam Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Harbin Pharmaceutical Group Sanjing Pharmaceutical Piracetam Injection Product Portfolio
6.4.5 Harbin Pharmaceutical Group Sanjing Pharmaceutical Recent Developments/Updates
6.5 Yangzhou Pharmaceutical
6.5.1 Yangzhou Pharmaceutical Corporation Information
6.5.2 Yangzhou Pharmaceutical Description and Business Overview
6.5.3 Yangzhou Pharmaceutical Piracetam Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Yangzhou Pharmaceutical Piracetam Injection Product Portfolio
6.5.5 Yangzhou Pharmaceutical Recent Developments/Updates
6.6 Rapid Life Drugs & Healthcare
6.6.1 Rapid Life Drugs & Healthcare Corporation Information
6.6.2 Rapid Life Drugs & Healthcare Description and Business Overview
6.6.3 Rapid Life Drugs & Healthcare Piracetam Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Rapid Life Drugs & Healthcare Piracetam Injection Product Portfolio
6.6.5 Rapid Life Drugs & Healthcare Recent Developments/Updates
6.7 Mits Healthcare Private Limited
6.6.1 Mits Healthcare Private Limited Corporation Information
6.6.2 Mits Healthcare Private Limited Description and Business Overview
6.6.3 Mits Healthcare Private Limited Piracetam Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Mits Healthcare Private Limited Piracetam Injection Product Portfolio
6.7.5 Mits Healthcare Private Limited Recent Developments/Updates
6.8 Psychocare
6.8.1 Psychocare Corporation Information
6.8.2 Psychocare Description and Business Overview
6.8.3 Psychocare Piracetam Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Psychocare Piracetam Injection Product Portfolio
6.8.5 Psychocare Recent Developments/Updates
6.9 Shinepro Lifesciences Pvt. Ltd.
6.9.1 Shinepro Lifesciences Pvt. Ltd. Corporation Information
6.9.2 Shinepro Lifesciences Pvt. Ltd. Description and Business Overview
6.9.3 Shinepro Lifesciences Pvt. Ltd. Piracetam Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Shinepro Lifesciences Pvt. Ltd. Piracetam Injection Product Portfolio
6.9.5 Shinepro Lifesciences Pvt. Ltd. Recent Developments/Updates
6.10 REPLEK FARM DOOEL
6.10.1 REPLEK FARM DOOEL Corporation Information
6.10.2 REPLEK FARM DOOEL Description and Business Overview
6.10.3 REPLEK FARM DOOEL Piracetam Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 REPLEK FARM DOOEL Piracetam Injection Product Portfolio
6.10.5 REPLEK FARM DOOEL Recent Developments/Updates
6.11 Dr Reddy's Laboratories Ltd
6.11.1 Dr Reddy's Laboratories Ltd Corporation Information
6.11.2 Dr Reddy's Laboratories Ltd Piracetam Injection Description and Business Overview
6.11.3 Dr Reddy's Laboratories Ltd Piracetam Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Dr Reddy's Laboratories Ltd Piracetam Injection Product Portfolio
6.11.5 Dr Reddy's Laboratories Ltd Recent Developments/Updates
6.12 Heilongjiang Fuhe Pharmaceutical
6.12.1 Heilongjiang Fuhe Pharmaceutical Corporation Information
6.12.2 Heilongjiang Fuhe Pharmaceutical Piracetam Injection Description and Business Overview
6.12.3 Heilongjiang Fuhe Pharmaceutical Piracetam Injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Heilongjiang Fuhe Pharmaceutical Piracetam Injection Product Portfolio
6.12.5 Heilongjiang Fuhe Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Piracetam Injection Industry Chain Analysis
7.2 Piracetam Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Piracetam Injection Production Mode & Process
7.4 Piracetam Injection Sales and Marketing
7.4.1 Piracetam Injection Sales Channels
7.4.2 Piracetam Injection Distributors
7.5 Piracetam Injection Customers
8 Piracetam Injection Market Dynamics
8.1 Piracetam Injection Industry Trends
8.2 Piracetam Injection Market Drivers
8.3 Piracetam Injection Market Challenges
8.4 Piracetam Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock